ISHIZAWA Kenichi | Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer
Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
Acquired hemophilia A with sigmoid colon cancer : successful treatment with rituximab followed by sigmoidectomy
A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma : β2-microglobulin associated with time to progression
Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
Plasma Cell Leukemia Maintaining Complete Remission by Syngeneic Stem Cell Transplantation Combined with Low-Dose Thalidomide Maintenance Therapy
Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

もっと見る

スポンサーリンク